Search research articles
Contact Us
Filters
Showing results (21-30 of 38) with videos related to
Page
of 4
Sort By:
Advanced Drug Delivery Reviews
|
October 30, 2016
Stem cell therapy clinical research: A regulatory conundrum for academia
Anjali Nagpal, Chris Juttner, Monica Anne Hamilton-Bruce, et al.
European Journal of Pain (London, England)
|
August 8, 2025
Reliability of Temporal Summation of Pain in Healthy and Clinical Populations: A Systematic Review and Meta-Analysis
Kexun Kenneth Chen, Paul Rolan, Mark Rowland Hutchinson, et al.
Pain Medicine (Malden, Mass.)
|
February 13, 2014
Reduced response to the thermal grill illusion in chronic pain patients
Nicole M Sumracki, Femke T A Buisman-Pijlman, Mark R Hutchinson, et al.
Plos One
|
June 12, 2012
The effects of pregabalin and the glial attenuator minocycline on the response to intradermal capsaicin in patients with unilateral sciatica
Nicole M Sumracki, Mark R Hutchinson, Melanie Gentgall, et al.
European Journal of Pain (London, England)
|
April 25, 2024
Exercise-induced changes in central sensitization outcomes in individuals with chronic musculoskeletal pain: A systematic review with meta-analysis
Kexun Kenneth Chen, Paul Rolan, Mark Rowland Hutchinson, et al.
British Journal of Clinical Pharmacology
|
October 22, 2009
A comparison of two formulations of intradermal capsaicin as models of neuropathic pain in healthy volunteers
Helena Gustafsson, Johanna Akesson, Chai Li Lau, et al.
Clinical Pharmacology in Drug Development
|
September 27, 2025
The Pathway to Proof-of-Concept for BNC210, a Negative Allosteric Modulator of the Alpha-7 Nicotinic Acetylcholine Receptor (nAChR), for Treatment of Psychiatric Disease
Paul Rolan, Elizabeth Doolin, Dharam Paul, et al.
Brain, Behavior, and Immunity
|
March 19, 2013
Low-dose endotoxin potentiates capsaicin-induced pain in man: evidence for a pain neuroimmune connection
Mark R Hutchinson, Mara Buijs, Jonathan Tuke, et al.
NEJM Evidence
|
December 8, 2024
BNC210, an α7 Nicotinic Receptor Modulator, in Post-Traumatic Stress Disorder
Spyridon Papapetropoulos, Elizabeth Doolin, Susan O'Connor, et al.
Psychiatry Research
|
February 15, 2025
A phase 2, placebo-controlled study to evaluate the efficacy and safety of BNC210, an alpha-7 nicotinic receptor negative allosteric modulator, for acute, as-needed treatment of social anxiety disorder (SAD) - The PREVAIL study
Spyros Papapetropoulos, Elizabeth Doolin, Michael Odontiadis, et al.
Page
of 4
Search research articles
Search
Showing results (21-30 of 38) with videos related to
Sort By:
Page
of 4
Advanced Drug Delivery Reviews
|
October 30, 2016
Stem cell therapy clinical research: A regulatory conundrum for academia
Anjali Nagpal, Chris Juttner, Monica Anne Hamilton-Bruce, et al.
European Journal of Pain (London, England)
|
August 8, 2025
Reliability of Temporal Summation of Pain in Healthy and Clinical Populations: A Systematic Review and Meta-Analysis
Kexun Kenneth Chen, Paul Rolan, Mark Rowland Hutchinson, et al.
Pain Medicine (Malden, Mass.)
|
February 13, 2014
Reduced response to the thermal grill illusion in chronic pain patients
Nicole M Sumracki, Femke T A Buisman-Pijlman, Mark R Hutchinson, et al.
Plos One
|
June 12, 2012
The effects of pregabalin and the glial attenuator minocycline on the response to intradermal capsaicin in patients with unilateral sciatica
Nicole M Sumracki, Mark R Hutchinson, Melanie Gentgall, et al.
European Journal of Pain (London, England)
|
April 25, 2024
Exercise-induced changes in central sensitization outcomes in individuals with chronic musculoskeletal pain: A systematic review with meta-analysis
Kexun Kenneth Chen, Paul Rolan, Mark Rowland Hutchinson, et al.
British Journal of Clinical Pharmacology
|
October 22, 2009
A comparison of two formulations of intradermal capsaicin as models of neuropathic pain in healthy volunteers
Helena Gustafsson, Johanna Akesson, Chai Li Lau, et al.
Clinical Pharmacology in Drug Development
|
September 27, 2025
The Pathway to Proof-of-Concept for BNC210, a Negative Allosteric Modulator of the Alpha-7 Nicotinic Acetylcholine Receptor (nAChR), for Treatment of Psychiatric Disease
Paul Rolan, Elizabeth Doolin, Dharam Paul, et al.
Brain, Behavior, and Immunity
|
March 19, 2013
Low-dose endotoxin potentiates capsaicin-induced pain in man: evidence for a pain neuroimmune connection
Mark R Hutchinson, Mara Buijs, Jonathan Tuke, et al.
NEJM Evidence
|
December 8, 2024
BNC210, an α7 Nicotinic Receptor Modulator, in Post-Traumatic Stress Disorder
Spyridon Papapetropoulos, Elizabeth Doolin, Susan O'Connor, et al.
Psychiatry Research
|
February 15, 2025
A phase 2, placebo-controlled study to evaluate the efficacy and safety of BNC210, an alpha-7 nicotinic receptor negative allosteric modulator, for acute, as-needed treatment of social anxiety disorder (SAD) - The PREVAIL study
Spyros Papapetropoulos, Elizabeth Doolin, Michael Odontiadis, et al.
Page
of 4